Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance

Abstract

In Year 5, we completed study enrollment. In total, 203 participants received the study intervention. Safety reports were sent to the study drug sponsor Actelion on a monthly basis. Both blinded and unblinded monitoring visits of study procedures and facilities are ongoing and should be completed by the end of October 2014. We are currently working on data cleaning, quality control efforts, and edit checks and hope to begin analyses in November 2014.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2014
Accession Number
ADA610837

Entities

People

  • Thomas Neylan

Organizations

  • Northern California Institute for Research and Education

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Anxiety Disorders
  • Brain
  • Brain Injuries
  • Chemical Synthesis
  • Chemistry
  • Data Science
  • Health Services
  • Medical Personnel
  • Neurons
  • Neurosciences
  • Psychiatry
  • Psychology

Readers

  • Neurotrauma and Rehabilitation Medicine.
  • Personnel Management and Statistics in the Military and Department of Defense
  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.